AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Over the past few years, API security has gone from a relatively niche concern to a headline issue. A slew of high-profile breaches and compliance mandates like PCI DSS 4.0 have woken security teams ...

For brands to thrive in today's ever-changing landscape, they must cultivate a deep understanding of their purpose. This ...

B y any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...

During the early 2000s, the word “gay” floated through casual speech like punctuation: a throwaway adjective that collapsed every deviation from straight, stoic masculinity into a single insult.

Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

A new technical paper titled “Massively parallel and universal approximation of nonlinear functions using diffractive ...